» Articles » PMID: 34950129

Flagellin From Modulates SARS-CoV-2 Infectivity in Cystic Fibrosis Airway Epithelial Cells by Increasing TMPRSS2 Expression

Overview
Journal Front Immunol
Date 2021 Dec 24
PMID 34950129
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

In the coronavirus disease 2019 (COVID-19) health crisis, one major challenge is to identify the susceptibility factors of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) in order to adapt the recommendations for populations, as well as to reduce the risk of COVID-19 development in the most vulnerable people, especially patients with chronic respiratory diseases such as cystic fibrosis (CF). Airway epithelial cells (AECs) play a critical role in the modulation of both immune responses and COVID-19 severity. SARS-CoV-2 infects the airway through the receptor angiotensin-converting enzyme 2, and a host protease, transmembrane serine protease 2 (TMPRSS2), plays a major role in SARS-CoV-2 infectivity. Here, we show that increases TMPRSS2 expression, notably in primary AECs with deficiency of the ion channel CF transmembrane conductance regulator (CFTR). Further, we show that the main component of flagella, the protein flagellin, increases TMPRSS2 expression in primary AECs and Calu-3 cells, through activation of Toll-like receptor-5 and p38 MAPK. This increase is particularly seen in Calu-3 cells deficient for CFTR and is associated with an intracellular increased level of SARS-CoV-2 infection, however, with no effect on the amount of virus particles released. Considering the urgency of the COVID-19 health crisis, this result may be of clinical significance for CF patients, who are frequently infected with and colonized by during the course of CF and might develop COVID-19.

Citing Articles

Establishment and characterization of persistent infections in air-liquid interface cultures of human airway epithelial cells.

Bouheraoua S, Cleeves S, Preusse M, Musken M, Braubach P, Fuchs M Infect Immun. 2025; 93(3):e0060324.

PMID: 39964154 PMC: 11895474. DOI: 10.1128/iai.00603-24.


Occurrence of COVID-19 in cystic fibrosis patients: a review.

Abolhasani F, Moein M, Rezaie N, Sheikhimehrabadi P, Shafiei M, Afkhami H Front Microbiol. 2024; 15:1356926.

PMID: 38694803 PMC: 11061495. DOI: 10.3389/fmicb.2024.1356926.


Bacterial Proteases as Potentially Exploitable Modulators of SARS-CoV-2 Infection: Logic from the Literature, Informatics, and Inspiration from the Dog.

Lushington G, Linde A, Melgarejo T BioTech (Basel). 2023; 12(4).

PMID: 37987478 PMC: 10660736. DOI: 10.3390/biotech12040061.


Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review.

Panzer B, Kopp C, Neumayer C, Koppensteiner R, Jozkowicz A, Poledniczek M Cells. 2023; 12(14).

PMID: 37508529 PMC: 10377790. DOI: 10.3390/cells12141865.


Expression of TMPRSS2 is up-regulated by bacterial flagellin, LPS, and Pam3Cys in human airway cells.

Schwerdtner M, Skalik A, Limburg H, Bierwagen J, Jung A, Dorna J Life Sci Alliance. 2023; 6(8).

PMID: 37208193 PMC: 10200810. DOI: 10.26508/lsa.202201813.


References
1.
Peckham D, McDermott M, Savic S, Mehta A . COVID-19 meets Cystic Fibrosis: for better or worse?. Genes Immun. 2020; 21(4):260-262. DOI: 10.1038/s41435-020-0103-y. View

2.
Elborn J . Cystic fibrosis. Lancet. 2016; 388(10059):2519-2531. DOI: 10.1016/S0140-6736(16)00576-6. View

3.
Walls A, Park Y, Tortorici M, Wall A, McGuire A, Veesler D . Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020; 183(6):1735. PMC: 7833104. DOI: 10.1016/j.cell.2020.11.032. View

4.
Cui B, Liu X, Fang Y, Zhou P, Zhang Y, Wang Y . Flagellin as a vaccine adjuvant. Expert Rev Vaccines. 2018; 17(4):335-349. DOI: 10.1080/14760584.2018.1457443. View

5.
Bouhaddou M, Memon D, Meyer B, White K, Rezelj V, Marrero M . The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell. 2020; 182(3):685-712.e19. PMC: 7321036. DOI: 10.1016/j.cell.2020.06.034. View